HOOKIPA Pharma (HOOK) Sof marja

HOOKIPA (HOOK) grafik logotipi

Barqaror foyda manbalarining yetishmasligi va tadqiqot va ishlanmalarga (R&D) kuchli bog'liqlik HOOKIPA Pharma Inc. (HOOK) uchun investitsiyalarga moliyaviy qaramlikni yuzaga keltirmoqda. GURU.Markets saytidagi ushbu grafik haqiqiy sof foyda marjasi tebranishlarni namoyish etishini ko'rsatadi, bunda 0.00 parametrning joriy holatini belgilaydi. Bu innovatsion virusli saraton vaksinalarining ishlab chiqilishi bilan bog'liqdir; biroq, geosiyosiy keskinliklar va logistik uzilishlar global klinik sinovlarning o'tkazilishiga jiddiy to'sqinlik qilmoqda.

hookipapharma.com (HOOK) Sotuvning sof marjinal rentabelligi: 04.07.2022 - 24.08.2025 davri uchun

hookipapharma.com (HOOK) kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
Kompaniyaning dastlabki tahlili:hookipapharma.com, HOOK
HOOKIPA Pharma Inc. ishlab chiqargan mahsulot

HOOKIPA Pharma Inc. (HOOK) tomonidan immunoterapiya platformalari va arenavirus vektorlarini ishlab chiqish tashqi shartnomaviy ishlab chiqarishga sezilarli xarajatlarni talab qiladi. Kompaniyaning GURU.Markets platformasidagi sof marja koeffitsiyenti barcha xarajatlar chegirib tashlanganidan keyin har bir dollar daromadning qancha qismi foyda ekanligini aks ettiradi. Ushbu grafikdagi manfiy qiymatlar biznesning operatsion yo'qotishlarini anglatadi. Ushbu tendentsiya metrikaning dinamikasini ko'rsatib, investorlarga pozitsiyani tugatish xavfini o'z vaqtida baholash imkonini beradi. Joriy daromadlilik emitentning bozor kapitalizatsiyasini bevosita belgilaydi.

HOOKIPA Pharma Inc. kimlar bilan raqobatlashadi

argenx (ARGX) - Sof marja|BNTX - Kompaniya sotuv marjasi|ABVX (Abivax Pharma) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ADMA Bio (ADMA)|Sof foyda bo'yicha sotuv rentabelligi PTGX (Protagonist Therapeutics Inc)|Sotuvning sof marjinal rentabelligi immunovant.com (IMVT)|Sof marja kiniksa.com KNSA|Grifols SA (GRFS) - Sof marja|Adaptive Biotechnologies Inc. - Sotuvning sof marjinal rentabelligi|Sof marja Celldex Therapeutics|AUPH: Sotuvning sof marjinal rentabelligi|BCRX - Kompaniya sotuv marjasi|VERA (Vera Corp) - Sotuvning sof marjinal rentabelligi|Dianthus Pharma (DNTH) - Kompaniya sotuv marjasi|Sof marja Pharvaris Pharma (PHVS)|Sotuvning sof marjinal rentabelligi AbCellera Corp (ABCL)|Sotuvning sof marjinal rentabelligi TRML (Tourmaline Bio Inc)|Kompaniya sotuv marjasi precigen.com (PGEN)|PHAR - Sof marja|Sof foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Sof foyda bo'yicha sotuv rentabelligi|Zenas Corp (ZBIO) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi IMNM|GOSS: Sof foyda normasi|Sof marja KalVista Pharma (KALV)|SEPN - Sof marja|Sotuvning sof marjinal rentabelligi PVLA (pieris.com)|Sotuvning sof marjinal rentabelligi Savara Pharma SVRA|RIGL: Sof foyda bo'yicha sotuv rentabelligi|ANAB - Sotuvning sof marjinal rentabelligi|ATXS: Sotuvning sof marjinal rentabelligi|ENGN - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi RAPT|JBIO (Aerovate Therapeutics Inc) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi ACRS|Sof foyda bo'yicha sotuv rentabelligi kyvernatx.com KYTX|Sotuvning sof marjinal rentabelligi TLSA (Tiziana Life Sciences, Ltd.)|Sotuvning sof marjinal rentabelligi Cabaletta Bio CABA|VTYX: Sof foyda bo'yicha sotuv rentabelligi|Theratechnologies Inc. (THTX) - Sof foyda bo'yicha sotuv rentabelligi|AVTX: Sotuvning sof marjinal rentabelligi|ELDN - Kompaniya sotuv marjasi|AGEN (Agenus, Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Climb Bio, Inc.|Sof marja Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi ADAG (Adagene Inc)|IMA - Sof foyda bo'yicha sotuv rentabelligi|STTK - Sof marja|EQ (equilliumbio.com) - Sotuvning sof rentabelligi|CNTB: Sotuvning sof marjinal rentabelligi|Immunic Inc (IMUX) - Sotuvning sof marjinal rentabelligi|ATRA (Atara Biotherapeutics Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Sof foyda normasi|Adicet Bio, Inc. - Sotuvning sof rentabelligi|Celularity Inc - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi INmune Bio Corporation INMB|Barinthus Biotherapeutics - Sotuvning sof marjinal rentabelligi|Kezar Life Sciences, Inc. (KZR) - Sof foyda bo'yicha sotuv rentabelligi|SAB Biotherapeutics Inc. (SABS) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi Akari Therapeutics plc|Sof marja enlivex.com|q32bio.com (QTTB) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi GOVX|Edesa Biotech, Inc. - Sotuvning sof rentabelligi|iBio Inc - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Carisma Therapeutics CARM|XTLB - Sof marja|BOLT (boltbio.com) - Sotuvning sof rentabelligi|HCWB: Sotuvning sof marjinal rentabelligi|Aptevo (APVO) - Sotuvning sof marjinal rentabelligi|Sof marja AIM ImmunoTech|Sof foyda bo'yicha sotuv rentabelligi Aditxt (ADTX)|Sof foyda bo'yicha sotuv rentabelligi GRI (GRI Bio Corporation)|XORTX - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi HIND (Vyome Holdings Inc.)|Sof foyda normasi REVB|Indaptus - Sotuvning sof marjinal rentabelligi|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning sof rentabelligi|CALI: Sotuvning sof marjinal rentabelligi|Affimed NV - Sof foyda normasi|Sof marja Allakos Inc.|igmbio.com (IGMS) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi ITOS|OCEA (Ocean Biomedical) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi TCBP (TC BioPharm (Holdings) PLC)|THRD - Sof foyda bo'yicha sotuv rentabelligi